175 related articles for article (PubMed ID: 30799695)
1. Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception.
Linher-Melville K; Sharma M; Nakhla P; Kum E; Ungard R; Park J; Rosa D; Gunning P; Singh G
Mol Pain; 2019; 15():1744806918823477. PubMed ID: 30799695
[TBL] [Abstract][Full Text] [Related]
2. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of TrkA inhibition on system x
Miladinovic T; Ungard RG; Linher-Melville K; Popovic S; Singh G
Mol Pain; 2018; 14():1744806918776467. PubMed ID: 29761734
[TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
Linher-Melville K; Haftchenary S; Gunning P; Singh G
Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
[TBL] [Abstract][Full Text] [Related]
5. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
6. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
Ungard RG; Seidlitz EP; Singh G
Pain; 2014 Jan; 155(1):28-36. PubMed ID: 23999057
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute to bone cancer pain.
Zhang J; Wang L; Wang H; Su Z; Pang X
Mol Pain; 2019; 15():1744806919830240. PubMed ID: 30717619
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
10. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
11. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Zhao J; Zhang H; Liu SB; Han P; Hu S; Li Q; Wang ZF; Mao-Ying QL; Chen HM; Jiang JW; Wu GC; Mi WL; Wang YQ
Neuroscience; 2013 Dec; 253():172-82. PubMed ID: 23988433
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
13. The relationship of bone-tumor-induced spinal cord astrocyte activation and aromatase expression to mechanical hyperalgesia and cold hypersensitivity in intact female and ovariectomized mice.
Smeester BA; O'Brien EE; Michlitsch KS; Lee JH; Beitz AJ
Neuroscience; 2016 Jun; 324():344-54. PubMed ID: 26995084
[TBL] [Abstract][Full Text] [Related]
14. Spinal microglia contribute to cancer-induced pain through system x
Miladinovic T; Singh G
Pain Rep; 2019; 4(3):e738. PubMed ID: 31583353
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
[TBL] [Abstract][Full Text] [Related]
16. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic Reticulum Stress Contributes to Nociception via Neuroinflammation in a Murine Bone Cancer Pain Model.
Mao Y; Wang C; Tian X; Huang Y; Zhang Y; Wu H; Yang S; Xu K; Liu Y; Zhang W; Gu X; Ma Z
Anesthesiology; 2020 Feb; 132(2):357-372. PubMed ID: 31939851
[TBL] [Abstract][Full Text] [Related]
18. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
19. Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.
Remeniuk B; King T; Sukhtankar D; Nippert A; Li N; Li F; Cheng K; Rice KC; Porreca F
Pain; 2018 Apr; 159(4):684-698. PubMed ID: 29300279
[TBL] [Abstract][Full Text] [Related]
20. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]